Literature DB >> 10376452

Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.

R B Fagundes1, S G de Barros, A C Pütten, E S Mello, M Wagner, L A Bassi, M A Bombassaro, D Gobbi, E B Souto.   

Abstract

BACKGROUND AND STUDY AIMS: Squamous cell carcinoma of the esophagus (SCCE) becomes symptomatic at a late stage when the disease is already advanced, and this contributes to its poor prognosis. Esophagoscopy of asymptomatic individuals exposed to known risk factors associated with the development of this cancer may facilitate the diagnosis of early cancerous or precancerous lesions; however, conventional esophagoscopy is not accurate enough. The aim of this study was to measure the value of Lugol chromoendoscopy of the esophagus (LCE) as an endoscopic technique to detect dysplasia in patients at risk. PATIENTS AND METHODS: We studied 190 male patients older than 35 attending an outpatient unit for alcoholics who consumed more than 80g of alcohol, more than 10 cigarettes and more than 500 ml 'maté' (a hot infusion of herbs) per day over 10 years. All underwent conventional upper gastrointestinal endoscopy followed by LCE, a spraying of Lugol 3% on the entire esophagus. All patients denied dysphagia. Biopsies were obtained from any unstained areas larger than 5mm and also from stained areas in all individuals. Biopsies were analyzed independently by two pathologists unaware of the biopsy sites. All conventional esophagoscopies showed normal mucosa, except for two suspicious small elevated lesions, confirmed histologically to be SCCE. These two cases were excluded from the statistical analysis.
RESULTS: The LCE found unstained areas in 23 patients and a uniformly stained esophageal mucosa in the remaining 165. Biopsies taken from these 23 unstained areas showed dysplasia in six (two high grade and four low grade), and the ones from the 165 stained areas taken at the middle esophagus showed low-grade dysplasia in seven. There was a high prevalence (6.9%) of dysplastic lesions in these individuals and occult dysplasia was significantly more frequent in unstained than stained areas (p = 0.0017). LCE showed a sensitivity of 46%, a specificity of 90%, a positive predictive value of 26% and a negative predicitve value of 96% when unstained areas were compared to stained ones. Agreement between two independent pathologists was high, with a kappa coefficient of 0.64.
CONCLUSION: We concluded that individuals who abuse alcohol, smoke and consume 'maté' have a high prevalence of dysplastic lesions that can be better detected by LCE. Esophagi with unstained areas had an eight-fold higher chance of revealing dysplasia than the uniformly stained ones. LCE is an easy and inexpensive method. It improves the detection of dysplasia and should be added to conventional upper GI endoscopy in patients at risk for SCCE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376452     DOI: 10.1055/s-1999-122

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  15 in total

1.  Esophageal squamous cell carcinoma - precursor lesions and early diagnosis.

Authors:  Antonio Barros Lopes; Renato Borges Fagundes
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

2.  Lugol chromoendoscopic screening for esophageal dysplasia/early squamous cell carcinoma in patients with esophageal symptoms in low-risk region in China.

Authors:  Ying Shao; Zhong-Lin Yu; Ming Ji; Yong-Dong Wu; Yong-Zheng Yu; Xiao-Mei Liang; L I Yu; Ying-Lin Niu; Peng Li; Shu-Tian Zhang
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

3.  Detection of superficial esophageal squamous cell neoplasia by chromoendoscopy-guided confocal laser endomicroscopy.

Authors:  Jin Huang; Yun-Sheng Yang; Zhong-Sheng Lu; Shuang-Fang Wang; Jing Yang; Jing Yuan
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening.

Authors:  Yasushi Yamasaki; Ryuta Takenaka; Keisuke Hori; Koji Takemoto; Seiji Kawano; Yoshiro Kawahara; Hiroyuki Okada; Shigeatsu Fujiki; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

5.  Update on endoscopic diagnosis, management and surveillance strategies of esophageal diseases.

Authors:  Fernando Fornari; Rafaela Wagner
Journal:  World J Gastrointest Endosc       Date:  2012-04-16

6.  Endoscopic resection of co-existing severe dysplasia and a small esophageal leiomyoma.

Authors:  Sun Young Ahn; Seong Woo Jeon
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Lack of Iodine Staining Lugol's Chromoendoscopy Predicts Squamous Neoplastic Progression in a High-risk Region of China: Implications for East and West.

Authors:  Cary C Cotton; Yash A Choksi
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-08       Impact factor: 11.382

8.  Screening for oesophageal neoplasia in patients with head and neck cancer.

Authors:  H Scherübl; B von Lampe; S Faiss; P Däubler; P Bohlmann; T Plath; H-D Foss; H Scherer; A Strunz; B Hoffmeister; H Stein; M Zeitz; E-O Riecken
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

Review 9.  Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.

Authors:  Massimiliano di Pietro; Marcia I Canto; Rebecca C Fitzgerald
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

10.  Narrow band imaging with magnification can pick up esophageal squamous cell carcinoma more efficiently than lugol chromoendoscopy in patients after chemoradiotherapy.

Authors:  Itsuko Asada-Hirayama; Shinya Kodashima; Mitsuhiro Fujishiro; Satoshi Ono; Keiko Niimi; Satoshi Mochizuki; Maki Konno-Shimizu; Rie Mikami-Matsuda; Chihiro Minatsuki; Chiemi Nakayama; Yu Takahashi; Nobutake Yamamichi; Kazuhiko Koike
Journal:  Diagn Ther Endosc       Date:  2013-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.